NICE recommends trametinib plus dabrafenib in melanoma
3 May 2016 | By Victoria White, Digital Content Producer
NICE has published final draft guidance recommending trametinib in combination with dabrafenib to treat some patients with melanoma...
List view / Grid view
News
3rd Pharmaceutical Traceability Forum to attract expert serialization and packaging professionals from across the nation
29 April 2016 | By 3rd Pharmaceutical Traceability Forum
Harmonize serialization plans to achieve compliance. Supply chain stakeholders must take a comprehensive view of their traceability strategy...
Sanofi makes $9.3b offer to acquire Medivation
28 April 2016 | By Victoria White, Digital Content Producer
Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi...
Positive topline results from a Phase Ib study of BioChaperone Lispro
28 April 2016 | By Victoria White, Digital Content Producer
Adocia and Lilly have announced positive topline results from a Phase Ib trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro...
Semaglutide reduces the risk of major adverse cardiovascular events in trial
28 April 2016 | By Victoria White, Digital Content Producer
The double-blinded SUSTAIN6 trial investigated the long-term cardiovascular and other safety outcomes of 0.5 mg and 1.0 mg semaglutide compared with placebo...
Novartis’ Ilaris provides hope for Periodic Fever Syndrome patients
27 April 2016 | By Mandy Parrett, Editorial Assistant
Novartis announced today that the FDA has granted three breakthrough therapy designations for Ilaris® (canakinumab) to treat rare types of Periodic Fever Syndromes, also known as Hereditary Periodic Fevers.
Watson-Marlow Fluid Technology Group is the world leader in niche peristaltic pumps and associated fluid path technologies
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow is the only company in the world able to provide a complete package of fluid path technology expertise to the biotechnology industries...
asepticSU™ single use technology eliminates cleaning validation
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
New Watson-Marlow 530 pumps deliver step-change improvements in validated process security for biopharm applications
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow Fluid Technology Group has introduced its new 530 peristaltic cased pump for upstream and downstream bioprocessing tasks...
Teaching machines to make clinical trials more successful
27 April 2016 | By Victoria White, Digital Content Producer
Researchers at are using so-called "machine learning" technologies to predict whether patients will participate in clinical trials...
NICE recommends heart failure drug Entresto
27 April 2016 | By Victoria White, Digital Content Producer
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.
EC grants marketing authorisation to Lonsurf in mCRC
27 April 2016 | By Victoria White, Digital Content Producer
The decision from the EC was based on data from the international, double-blind, placebo-controlled Phase III RECOURSE study...
NICE says ‘yes’ to two ovarian cancer drugs, rejects three
27 April 2016 | By Victoria White, Digital Content Producer
The guidance recommends paclitaxel and PLDH for treating ovarian cancer that has returned after previous chemotherapy treatment...
The global cost of norovirus
26 April 2016 | By Victoria White, Digital Content Producer
Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
Promising top-line results for AZP-531 in Prader-Willi Syndrome
26 April 2016 | By Victoria White, Digital Content Producer
Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)...
